Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Hall

Showing results (361-370 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Clinical Investigation|December 15, 2025
Interlocking host and viral cis-regulatory networks drive Merkel cell carcinomaLingling Miao, David Milewski, Amy Coxon, et al.
Science (New York, N.Y.)|May 19, 2012
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 peopleMatthew R Nelson, Daniel Wegmann, Margaret G Ehm, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Cancer Research|August 22, 2019
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing SarcomaChoh Yeung, Anna E Gibson, Sameer H Issaq, et al.
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Journal of Neuro-Oncology|August 29, 2019
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201Andrew S Chi, Rohinton S Tarapore, Matthew D Hall, et al.
Nature|July 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunityJanna Heide, Agnes J Bilecz, Samarjit Patnaik, et al.
The Journal of Infectious Diseases|September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug DevelopmentRobert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Journal of Medicinal Chemistry|April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of CancerJason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Journal of Medicinal Chemistry|November 10, 2017
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)Ganesha Rai, Kyle R Brimacombe, Bryan T Mott, et al.
Pageof 39

Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Investigation|December 15, 2025
Interlocking host and viral cis-regulatory networks drive Merkel cell carcinomaLingling Miao, David Milewski, Amy Coxon, et al.
Science (New York, N.Y.)|May 19, 2012
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 peopleMatthew R Nelson, Daniel Wegmann, Margaret G Ehm, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Cancer Research|August 22, 2019
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing SarcomaChoh Yeung, Anna E Gibson, Sameer H Issaq, et al.
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Journal of Neuro-Oncology|August 29, 2019
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201Andrew S Chi, Rohinton S Tarapore, Matthew D Hall, et al.
Nature|July 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunityJanna Heide, Agnes J Bilecz, Samarjit Patnaik, et al.
The Journal of Infectious Diseases|September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug DevelopmentRobert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Journal of Medicinal Chemistry|April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of CancerJason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Journal of Medicinal Chemistry|November 10, 2017
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)Ganesha Rai, Kyle R Brimacombe, Bryan T Mott, et al.
Pageof 39